Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer.
Goya H, Kuraishi H, Koyama S, Ichiyama T, Yoshiike F, Hirai K, Agatsuma T, Tateishi K, Kanda S, Yamamoto H, Kubo K, Koizumi T. Goya H, et al. Among authors: hirai k. Cancer Chemother Pharmacol. 2012 Nov;70(5):691-7. doi: 10.1007/s00280-012-1957-0. Epub 2012 Sep 1. Cancer Chemother Pharmacol. 2012. PMID: 22941346 Clinical Trial.
Clinical outcomes in elderly patients administered gefitinib as first-line treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer: retrospective analysis in a Nagano Lung Cancer Research Group study.
Tateishi K, Ichiyama T, Hirai K, Agatsuma T, Koyama S, Hachiya T, Morozumi N, Shiina T, Koizumi T. Tateishi K, et al. Among authors: hirai k. Med Oncol. 2013 Mar;30(1):450. doi: 10.1007/s12032-012-0450-2. Epub 2013 Jan 13. Med Oncol. 2013. PMID: 23315220 Free article.
Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancer.
Fukushima T, Wakatsuki Y, Kobayashi T, Sonehara K, Tateishi K, Yamamoto M, Masubuchi T, Yoshiike F, Hirai K, Hachiya T, Koizumi T. Fukushima T, et al. Among authors: hirai k. Cancer Chemother Pharmacol. 2018 Jun;81(6):1043-1050. doi: 10.1007/s00280-018-3573-0. Epub 2018 Apr 11. Cancer Chemother Pharmacol. 2018. PMID: 29644460 Clinical Trial.
Gefitinib as first-line treatment in elderly epidermal growth factor receptor-mutated patients with advanced lung adenocarcinoma: results of a Nagano Lung Cancer Research Group study.
Asami K, Koizumi T, Hirai K, Ameshima S, Tsukadaira A, Morozumi N, Morikawa A, Atagi S, Kawahara M. Asami K, et al. Among authors: hirai k. Clin Lung Cancer. 2011 Nov;12(6):387-92. doi: 10.1016/j.cllc.2011.02.004. Epub 2011 May 10. Clin Lung Cancer. 2011. PMID: 21729650 Clinical Trial.
A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
Kosaka M, Ushiki A, Ikuyama Y, Hirai K, Matsuo A, Hachiya T, Hanaoka M. Kosaka M, et al. Among authors: hirai k. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01173-17. doi: 10.1128/AAC.01173-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28893787 Free PMC article.
Silica-associated systemic lupus erythematosus in an elderly man.
Yamazaki S, Yoshiike F, Hirai K, Kakegawa T, Ikeda M, Nagata A, Saito G, Nishimura H, Hosaka N, Ehara T. Yamazaki S, et al. Among authors: hirai k. Intern Med. 2007;46(22):1867-71. doi: 10.2169/internalmedicine.46.0015. Epub 2007 Nov 16. Intern Med. 2007. PMID: 18025770 Free article.
2,086 results